BLISSGVS Financial Statements

Bliss GVS Pharma Profit & Loss Statement

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2018
Growth matrix (%)        
Revenue growth 29.50 (16) (15) 2.03
Op profit growth 11 (13) (37) (2.80)
EBIT growth 20.90 (26) (27) 3.69
Net profit growth (78) (30) 65.50 (28)
Profitability ratios (%)        
OPM 15.80 18.50 17.90 24.20
EBIT margin 17.70 19 21.40 24.80
Net profit margin 2.01 11.90 14.10 7.22
RoCE 13.70 11.90 18.90 27.70
RoNW 0.46 2.22 3.82 2.87
RoA 0.39 1.86 3.12 2.01
Per share ratios ()        
EPS 2.23 7.17 9.23 8.60
Dividend per share 0.50 0.50 0.50 1
Cash EPS (0.20) 4.97 8.21 3.63
Book value per share 79 78.40 71.30 52
Valuation ratios        
P/E 34.50 13.80 10.90 22.70
P/CEPS (348) 19.90 12.30 53.90
P/B 0.97 1.26 1.41 3.76
EV/EBIDTA 4.87 7.85 6.63 9.14
Payout (%)        
Dividend payout -- -- -- 17.50
Tax payout (24) (29) (24) (32)
Liquidity ratios        
Debtor days 209 320 224 124
Inventory days 54.40 55.60 36 24.30
Creditor days (57) (68) (49) (59)
Leverage ratios        
Interest coverage (28) (20) (27) (8.90)
Net debt / equity (0.10) -- 0.03 0.05
Net debt / op. profit (0.60) (0.20) 0.19 0.15
Cost breakup ()        
Material costs (52) (57) (64) (48)
Employee costs (10) (12) (7.80) (8.50)
Other costs (22) (13) (11) (19)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Revenue 747 577 689 815
yoy growth (%) 29.50 (16) (15) 2.03
Raw materials (391) (329) (440) (391)
As % of sales 52.30 57 63.80 48
Employee costs (76) (68) (54) (69)
As % of sales 10.20 11.80 7.79 8.50
Other costs (162) (74) (72) (157)
As % of sales 21.70 12.70 10.50 19.30
Operating profit 118 107 123 197
OPM 15.80 18.50 17.90 24.20
Depreciation (17) (17) (13) (21)
Interest expense (4.70) (5.50) (5.40) (23)
Other income 31.50 20.20 37.10 26.50
Profit before tax 128 104 142 179
Taxes (31) (30) (34) (57)
Tax rate (24) (29) (24) (32)
Minorities and other (8.10) (5.50) 2.01 (30)
Adj. profit 88.60 68.50 111 93
Exceptional items (74) -- (13) (34)
Net profit 15 68.50 97.30 58.80
yoy growth (%) (78) (30) 65.50 (28)
NPM 2.01 11.90 14.10 7.22
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Profit before tax 128 104 142 179
Depreciation (17) (17) (13) (21)
Tax paid (31) (30) (34) (57)
Working capital 507 491 422 256
Other operating items -- -- -- --
Operating cashflow 587 547 518 357
Capital expenditure 303 221 70.80 (99)
Free cash flow 890 769 589 259
Equity raised 950 930 876 754
Investments 2.39 (0.80) 0.01 0.01
Debt financing/disposal 104 87.30 3.36 25.40
Dividends paid -- -- -- 10.30
Other items -- -- -- --
Net in cash 1,946 1,785 1,468 1,048
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2019
Equity capital 10.40 10.30 10.30 10.30
Preference capital -- -- -- --
Reserves 808 798 725 636
Net worth 819 808 736 646
Minority interest
Debt 109 122 126 102
Deferred tax liabilities (net) 14.50 11.80 7.13 4.54
Total liabilities 970 962 884 766
Fixed assets 304 237 242 192
Intangible assets
Investments 2.39 0.01 0.02 0.02
Deferred tax asset (net) 13.20 3.59 3.57 0.96
Net working capital 474 577 535 466
Inventories 124 98.90 76.90 77.40
Inventory Days 60.50 62.60 40.70 --
Sundry debtors 393 464 548 461
Debtor days 192 293 290 --
Other current assets 109 133 60.20 67.70
Sundry creditors (118) (80) (94) (93)
Creditor days 57.50 50.70 49.90 --
Other current liabilities (34) (39) (56) (47)
Cash 178 145 103 107
Total assets 970 962 884 766
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Jun-2022 Mar-2022 Dec-2021 Sep-2021 Jun-2021
Gross Sales 189 167 216 196 168
Excise Duty -- -- -- -- --
Net Sales 189 167 216 196 168
Other Operating Income -- -- -- -- --
Other Income 7.01 12.20 6.04 5.45 7.82
Total Income 196 179 222 201 176
Total Expenditure ** 150 147 256 167 134
PBIDT 45.90 32.40 (33) 34.90 42.40
Interest 2.11 1.63 1.04 0.68 1.40
PBDT 43.80 30.70 (34) 34.20 41
Depreciation 4.55 4.27 4.43 4.30 4.33
Minority Interest Before NP -- -- -- -- --
Tax 10.40 2.03 12.20 12 9.57
Deferred Tax 1.32 0.96 (2.60) (4.10) 0.99
Reported Profit After Tax 27.50 23.50 (49) 22.10 26.10
Minority Interest After NP 1.76 3.83 1.58 0.79 1.88
Net Profit after Minority Interest 25.70 19.60 (50) 21.30 24.30
Extra-ordinary Items -- -- (61) -- --
Adjusted Profit After Extra-ordinary item 25.70 19.60 11.30 21.30 24.30
EPS (Unit Curr.) 2.48 1.90 (4.80) 2.05 2.35
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 10.40 10.40 10.40 10.40 10.30
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 24.30 19.40 (15) 17.80 25.20
PBDTM(%) 23.20 18.40 (16) 17.40 24.40
PATM(%) 14.60 14 (22) 11.30 15.50
Open ZERO Brokerage Demat Account
Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity